|
|
|
July 31st, 2012
|  Editor: Ahmed Enany
President & CEO
Southern California
Biomedical Council
enany@socalbio.org
www.socalbio.org
|
| RSVP Now |
This is a meeting of bioscience women executives and allied service providers affiliated with SoCalBio to encourage women entrepreneurship in the biosciences.
Featuring a Keynote Presentation About
Effective BioPartnering
by
Linda Pullan, Pullan Consulting
| |
|
| Reserve Your Spot | |
|
| SoCalBio Workforce Summit | |
Thanks to Bioscience Executives, Educators and Workforce Training Professionals Who Attended the SoCalBio Workforce Summit Held July 19 at the LA Chamber of Commerce
|
|
|
 |
Replenish Inc. -- a Pasadena-based developer of devices for drug delivery -- came to the Summit to fill 19 engineering positions
|
| |
|
 | | Sean Caffey, MD, President & CEO, Replenish Inc. (Pasadena) networks with Albert Oaten, VP ,AppFolio SecureDocs(Santa Barbara) |
|
|
| Public Policy |
Battle Over Genetically Engineered Food
Heading to Voters
 A fight over genetically engineered foods has been heating up in the nation's grocery aisles. Now it's headed for the ballot box. Voters will soon decide whether to make California the first state in the country to require labels on products such as sweet corn whose genes have been altered to make them resistant to pests ... Read more at the LA Times
Your Opinion Matters to SoCalBio
Are you for or against labeling GM food?
Click here to vote
(voting is anonymous)
|
| Funding | |
CIRM Allocates $150 Million to Academic Institutions and Industry to Develop New Treatments
UCLA, UCI and Cedars Sinai are among grant winners
 The grants, up to $20 million per applicant, go to teams of researchers in both academia and industry who have been working on projects that represent the best possible chances of producing therapies for deadly and disabling diseases and disorders. Those diseases include Huntington's disease, metastatic melanoma, osteoporosis, critical limb ischemia, spinal cord injury, ALS (Lou Gehrig's disease) and cardiovascular disease... Read more
|
| Bioscience Growth Strategy | |
SoCalBio Forms an Advisory Board to Support Battelle Technology Partnership's Efforts in Generating a Biocience Industry Growth Strategy for Los Angeles
 The Advisory board -- whose members to be announced soon -- will provide guidance in developing the much-needed strategic plan for growing the County's bioscience industry cluster. "We have a start date of August 1st and we look forward to working with the bioscience industry in Los Angeles under the leadership of SoCalBio and other stakeholders to chart a biosciece industry growth map for the County," said Mitch Horowitz (photo right), Vice President and Managing Director, Battelle's Technology Partnership Practice .... Learn more about Battelle Technology Partnership
|
| Collaboration |
 NantPharma has provided an initial $2.5 million to NantPro, which in turn paid ProMetic to access its technology rights and to manufacture cGMP bulk active batches to enable the IND filing and provide the product required for bioequivalence clinical trials at its Laval facility. "Plasma-derived products are urgently needed for the treatment of auto-immune and other diseases," said NantPharma's chairman Patrick Soon-Shiong (photo right) ... Read more
|
| Ophthalmic Device |
Second Sight's Retinal Implant -- Argus II -- Will Be Up for Review by the FDA in September
The device is the first of its kind in enabling partial vision in patients blinded by retinitis pigmentosa
 The data presented in the HDE application will be discussed by the advisory panel. If FDA market approval is granted, the Argus II system will become the first ever retinal prosthesis to gain approval in the U.S. The system became the only approved retinal prosthesis anywhere in the world when it received CE Mark approval in Europe last year .. Read more
|
| Telemedicine |
 InTouch supplied the telemedicine part and iRobot developed the motion and navigation aspects of the RP-VITA, which uses sensors and smart algorithms to help a physician move through a hospital's complicated terrain. There's even talk of a "single click" feature to be approved by the FDA that seems to allow the RP-VITA to autonomously navigate between patients in a hospital that the remote physician might not even know the topography of ... Read more
|
| On the Move |
 Mr. Step brings over 20 years of corporate development experience in the biotechnology and pharmaceutical industry. His knowledge and ties into the gastrointestinal field further strengthens the leadership at Ritter Pharma as it continues to build its presence in gastroenterology. Mr. Step will serve as an independent director and will assist in developing and maintaining strategic relationships, corporate business development activities, as well as provide guidance in all aspects of the pharmaceutical lifecycle. "We are pleased to have Mike join Ritter Pharma's Board of Directors," said Ritter Pharma's President and Chief Executive Officer, Andrew Ritter (photo right). "Mike's enthusiasm and forward thinking will add a unique perspective to help drive our strategic path forward. We are looking forward to Mike's participation and his valuable guidance" ... Read more
|
| New SoCalBio Members | |
Ritter Pharmaceuticals (Los Angeles)
 Ritter Pharmaceuticals, Inc. is a specialty pharmaceutical company developing therapeutics based upon colonic adaptation to treat gastrointestinal diseases with an initial focus on lactose intolerance
. Colonic adaptation improves colon function by selectively increasing the growth of beneficial bacteria in the colonic ecosystem (digestive tract) ... Learn more
NanoSmart Pharmaceuticals, Inc. (Laguna Hills)
Vince and Associates Clinical Research (Irvine)
 Vince and Associates Clinical Research is an industry leader that provides comprehensive multi-specialty (Phase I - III) clinical trial services to the pharmaceutical and biotech industry ... Learn more
BionCR (Irvine)
 BionCR Development is a biopharmaceutical company translating highly innovative scientific research into drug development programs for patient populations with unmet and critical clinical needs .... Learn more
Exponent (Menlo Park, Los Angeles & Irvine)
 Exponent is an engineering and scientific consulting firm providing solutions to complex problems. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future ... Learn more
Integrity Bio, Inc. (Camarillo)
 Integrity Bio, Inc. provides formulation development, process development, and contract manufacturing services for biotechnology, pharmaceutical, and medical device companies in the United States and internationally. ...Learn more
Claremont BioSolutions (Upland)
 Claremont BioSolutions (ClaremontBio) is dedicated to next-generation devices for lysis and nucleic acid extraction from microbial cells for PCR ready sample. This novel technology can be applied to point-of-care systems, mini flow through platforms and various other integrations ... Learn more
One3 IP Management (Newbury Park)
One3 IP is dedicated to intellectual property management. The company is represented in SoCalBio by its CEO Peter Weinstein peter_weinstein@one3ip.com
|
| SoCalBio Membership Saves You Money | |
Become a SoCalBio Member and save money through utlizing the SoCalBio Group Purchasing Program
Video Recap of SoCalBio Open House
|
|
| About SoCalBio |
 SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
|
|
NanoSmart Pharma is developing immunoliposomal drugs for treating cancer. Learn more about the company at: